Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients - sprookjes - yvandenbroek - TriplyDB

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

http://www.wikidata.org/entity/Q28366039

about

The regulation of MMP targeting to invadopodia during cancer metastasis Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells Comparative Effects of Non-Thermal Atmospheric Pressure Plasma on Migration and Invasion in Oral Squamous Cell Cancer, by Gas Type.Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9 Sulforaphane controls TPA-induced MMP-9 expression through the NF-κB signaling pathway, but not AP-1, in MCF-7 breast cancer cells.Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF-κB-dependent MMP-9 expression.Saussurea lappa extract suppresses TPA-induced cell invasion via inhibition of NF-κB-dependent MMP-9 expression in MCF-7 breast cancer cells.Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.Polyadenylate polymerase (PAP) and 3' end pre-mRNA processing: function, assays, and association with disease.Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.Targeting the tumor microenvironment: focus on angiogenesis.Matrix metalloproteinases: protective roles in cancer.Breast cancer biomarkers and molecular medicine: part II.Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-κB signaling pathway in MDA-MB-231 human breast cancer cells Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.Euphorbia humifusa Willd exerts inhibition of breast cancer cell invasion and metastasis through inhibition of TNFα-induced MMP-9 expression.Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo Suppression of TPA-induced cancer cell invasion by Peucedanum japonicum Thunb. extract through the inhibition of PKCα/NF-κB-dependent MMP-9 expression in MCF-7 cells.Inhibition of stathmin1 accelerates the metastatic process.The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.Primary tumour-vessel tumour-nodal tumour classification for patients with invasive ductal carcinoma of the breast.The tumor microenvironment: key to early detection.Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.In vivo investigation of breast cancer progression by use of an internal control.Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness.Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-γ/NF-κB pathway in MCF-7 cells.MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors

P2860

Q21131317-3BD089F8-7F62-4130-864E-DD66FE1B1B55 Q24642830-0B0DDDA8-4F27-433E-BD36-E5EA81E4F989 Q24803543-61D420D3-0B88-41B9-A943-5C6E578E6317 Q26769949-0D2EB956-B460-473B-8494-A4531FC31120 Q26798254-149212EB-40BC-45BF-AC9B-6889DE2A70B2 Q28209528-02A2D585-691E-4025-B1A8-27FC7B27C6B3 Q33469690-8AE22944-34B7-4100-8E84-5C92C6EC482F Q33757096-C4B4CD50-A4B6-4818-A216-848314720F20 Q33904564-429F7C74-583D-4961-AD10-507EEFC792C2 Q34049288-893BD16C-8B99-4F17-9805-E20A327C688E Q34049460-8C06F8F0-E96B-4CAB-894D-A72E1DD0EC4B Q34049715-A5F9F3E7-3AF0-42C7-A5D8-609FBAA4D353 Q34210631-5A69A1D8-F471-47AE-A67C-66F412230E5D Q34371654-EECDFBC3-2218-4B6B-8C4A-059A28CCAE90 Q34372172-7FF3E99F-2800-47B0-8649-5B95E879C20B Q34501113-2B772F8A-615A-4FBD-BE35-93A0A1BFA574 Q34502296-86720547-3415-4BEA-8225-AE9507DDECD0 Q34743681-7664808D-1A4A-4676-BC9C-9F7F67351AFD Q35143905-6108817C-12D3-4334-ACC9-62BFF0ECE8B3 Q35184806-707E5AF4-8261-4F08-BF4F-55C97911EF9A Q35216059-80A3D6FC-6662-4C0B-B3C3-E5ACA73E0266 Q35680309-83ADD852-795C-46E6-B1D1-86B3345DAE05 Q35803849-46990E4F-C504-487C-819A-22BD976D05F0 Q35916537-67A8A877-A374-4AEA-81BC-C522A7996418 Q36173467-AD054DF4-3E89-4C72-BCA6-8A5BB4BA028D Q36227449-D2BD25BA-54CF-40F7-BF5A-4127F2DA5189 Q36393973-99666F70-3083-471F-8F1F-B686944975E5 Q36528542-47F643D0-FB2F-42A5-902C-BEA502D75681 Q36610051-F5D7FB69-D3F6-4CEC-9258-E8840F772946 Q36616299-73744CA0-2EE5-492C-A174-B6F1C1811E06 Q36627750-460A07A8-E9C7-4407-A201-82BD395F61D1 Q36642442-F9356E76-F6F2-4D8A-8D9E-A3838D0C8EBD Q36986233-DEF48857-296C-4A55-A5A1-8AA7336E18D0 Q37038590-ED7591E4-96E8-4C5B-B974-6D2E62C98335 Q37109529-88329356-5E8E-4A62-8F0D-0F80B25DDE15 Q37206817-FCEF8256-DDC1-441A-BB5D-F0800DA683F9 Q37355100-9B66DFE7-150D-4016-B8E3-2EDA00E95E4D Q37461337-2B9BA0E7-9EBB-4283-A5BC-3EFC70B3D5CB Q37594250-86E7B352-AE9F-4290-A9A3-CA681EE83250 Q37600292-18CC25A8-2D9F-4960-9892-755CD367D52E

P2860

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

http://www.wikidata.org/entity/Q28366039

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Overexpression of matrix-metal ...... ator in node-negative patients

@ast

Overexpression of matrix-metal ...... ator in node-negative patients

@en

Overexpression of matrix-metal ...... ator in node-negative patients

@nl

type

label

Overexpression of matrix-metal ...... ator in node-negative patients

@ast

Overexpression of matrix-metal ...... ator in node-negative patients

@en

Overexpression of matrix-metal ...... ator in node-negative patients

@nl

prefLabel

Overexpression of matrix-metal ...... ator in node-negative patients

@ast

Overexpression of matrix-metal ...... ator in node-negative patients

@en

Overexpression of matrix-metal ...... ator in node-negative patients

@nl

P1433

Q28366039-20932AA8-4619-47DE-9F20-B111C40366F1

P1476

Q28366039-0BEE8426-7D28-4826-A5D7-B9EA0AA79C31

P2093

Q28366039-02B1D70D-0770-4840-8D48-8BE772F887B5

Q28366039-078C63C4-1D95-45C2-9CE4-77A394C7E042

Q28366039-09C4667B-8D8C-44C7-ACBA-35C8E694CE5D

Q28366039-65D85F6F-8C72-492B-B2EE-773297E4DF17

Q28366039-A62AC06C-F913-4E76-B691-37C68C84342B

P2860

Q28366039-01F90EF7-E2B1-4E34-8F51-F9C5DB21B3E8

Q28366039-05003B71-30B2-42C1-923A-8A35B88F7DC5

Q28366039-09F5822E-298B-4029-831B-4FA6A078B0F6

Q28366039-0E9B2D09-AE5D-420B-B019-3E62A24D3D93

Q28366039-1873AB52-6332-40B4-8AF1-2FCC038B7F53

Q28366039-216A5E82-59D5-4819-BA4B-800CBE231BB6

Q28366039-3AA7D128-8CD6-4DF7-8C75-B887330ED73B

Q28366039-5AAFB8A5-643B-48A6-92BA-60223AF61B03

Q28366039-6317C003-942C-4FE3-93A3-97C7BD89F674

Q28366039-65AAF14C-1177-4BA8-80D4-0923408E4A1C

P2888

Q28366039-AE27C5ED-3F0B-49FA-A370-F5348E475930

P304

Q28366039-F78E8ADD-E792-437F-8B9F-22E1A26744F6

P31

Q28366039-FA547B51-E150-4E68-9471-380A7B01046C

P3181

Q28366039-A6541426-D196-449F-9866-FF9A774A9C07

P356

Q28366039-CCAB769A-F785-40AB-B289-83EA4A94989C

P407

Q28366039-EA39C1A1-DCF8-46E5-8564-660898374249

P433

Q28366039-E1A26A75-8B14-495C-AC7A-D9E559D08D35

P478

Q28366039-FE737427-31EC-4296-8059-8501E7650E33

P50

Q28366039-BE126C06-4AA0-4458-8F2E-0ECB171532A6

Q28366039-FEEA7666-E581-4CCA-94E9-EE846DDBF2E1

P577

Q28366039-D69183D3-6DBF-48F9-B76C-E050678D059B

P5875

Q28366039-4E0D8E3F-5D56-485F-A4A9-9F53BBDB2D62

P6179

Q28366039-0D35EE27-17EA-48D7-82AA-205D69530712

P698

Q28366039-F478637E-4DA9-4210-BE7E-6B0B089FACA9

P921

Q28366039-A315946F-8678-4321-B707-C68204F87B81

Q28366039-EC786A88-7950-406C-ADAE-F71AEA7EB585

P932

Q28366039-07F6A8C8-1A08-44F2-8788-43B93D473F62

P3181

P356

P1433

British Journal of Cancer

P1476

Overexpression of matrix-metal ...... ator in node-negative patients

@en

P2093

A Ardavanis

http://www.w3.org/2001/XMLSchema#string

A Karameris

http://www.w3.org/2001/XMLSchema#string

N Arnogiannaki

http://www.w3.org/2001/XMLSchema#string

P Bassilopoulos

http://www.w3.org/2001/XMLSchema#string

T Trangas

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer

Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family

Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.

Matrix metalloproteinases: biologic activity and clinical implications.

Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene.

Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

P2888

P304

1488-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2830850

http://www.w3.org/2001/XMLSchema#string

P356

10.1054/BJOC.2001.1810

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Scorilas

Maroulio Talieri

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11955158

http://www.w3.org/2001/XMLSchema#string

P6179

1020370891

http://www.w3.org/2001/XMLSchema#string

P698

11384099

http://www.w3.org/2001/XMLSchema#string

P921

P932

2363667

http://www.w3.org/2001/XMLSchema#string